(Q35922170)

11 August 2017

1 reference

title

Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile (English)

1 reference

11 August 2017

Kenichi Yasunari

1

1 reference

11 August 2017

Kensaku Maeda

2

1 reference

11 August 2017

Munehiro Nakamura

3

1 reference

11 August 2017

Takanori Watanabe

4

1 reference

11 August 2017

Junichi Yoshikawa

5

1 reference

11 August 2017

Akira Asada

6

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Cardiovascular Drug Reviews

11 August 2017

published in

1 reference

11 August 2017

volume

22

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

189-198

1 reference

Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2004.TB00140.X

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2004.TB00140.X

Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2004.TB00140.X

Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2004.TB00140.X

10.1111/J.1527-3466.2004.TB00140.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference